Garlic supplementation improves intestinal transit time, lipid accumulation product and cardiometabolic indices in subjects with metabolic syndrome: A randomized controlled trial

Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powd...

Full description

Saved in:
Bibliographic Details
Published inPhytotherapy research Vol. 37; no. 6; pp. 2305 - 2314
Main Authors Sangouni, Abbas Ali, Alizadeh, Mohammad, Jamalzehi, Atena, Hosseinzadeh, Mahdieh, Parastouei, Karim
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.06.2023
Wiley Subscription Services, Inc
Subjects
Accumulation
cardiometabolic
Cardiovascular Diseases
Clinical trials
Diet
Dietary Supplements
Garlic
gastrointestinal transit
Health risks
Heart diseases
Humans
Intestinal microflora
intestinal microorganisms
Intestinal transit time
Intestine
Lipid Accumulation Product
Lipids
Metabolic disorders
Metabolic syndrome
Metabolic Syndrome - therapy
Pathogenesis
phytotherapy
Placebos
Powder
Powders
Random numbers
randomized clinical trials
Risk
Transit time
metabolic syndrome
garlic
lipid accumulation product
cardiometabolic
intestinal transit time
Online AccessGet full text

Cover

Abstract Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double‐blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer‐generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow‐up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI‐I) and Castelli risk index II (CRI‐II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (−21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (−0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (−0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI‐I (−0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI‐II (−0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
AbstractList Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double-blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer-generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow-up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI-I) and Castelli risk index II (CRI-II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (-21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (-0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (-0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI-I (-0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI-II (-0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double-blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer-generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow-up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI-I) and Castelli risk index II (CRI-II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (-21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (-0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (-0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI-I (-0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI-II (-0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double-blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer-generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow-up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI-I) and Castelli risk index II (CRI-II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (-21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (-0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (-0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI-I (-0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI-II (-0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double‐blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer‐generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow‐up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI‐I) and Castelli risk index II (CRI‐II). Garlic powder compared to the placebo improved intestinal transit time ( p  = .001), LAP (−21.5 ± 23.4 vs. 0.7 ± 21.5; p  < .001), CMI (−0.85 ± 0.8 vs. 0.13 ± 0.8; p  < .001), AIP (−0.14 ± 0.1 vs. 0.01 ± 0.1; p  < .001), CRI‐I (−0.69 ± 0.5 vs. 0.16 ± 0.5; p  < .001) and CRI‐II (−0.50 ± 0.3 vs. 0.02 ± 0.3; p  < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double‐blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer‐generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow‐up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI‐I) and Castelli risk index II (CRI‐II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (−21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (−0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (−0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI‐I (−0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI‐II (−0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS. It has been hypothesized that garlic can improve intestinal transit time and cardiovascular risks. We investigated the effect of garlic powder supplementation on intestinal transit time, lipid accumulation product (LAP), and cardiometabolic indices in subjects with MetS. A double‐blind randomized controlled trial was conducted for 3 months among subjects with MetS. Ninety subjects were randomly assigned to the treatment group (intake of 1,600 mg/d garlic powder) or control group (placebo) using a computer‐generated random number table. All participants were asked to follow the common healthy dietary recommendations during follow‐up. The primary outcomes included intestinal transit time, LAP, cardiometabolic index (CMI), atherogenic index of plasma (AIP), Castelli risk index I (CRI‐I) and Castelli risk index II (CRI‐II). Garlic powder compared to the placebo improved intestinal transit time (p = .001), LAP (−21.5 ± 23.4 vs. 0.7 ± 21.5; p < .001), CMI (−0.85 ± 0.8 vs. 0.13 ± 0.8; p < .001), AIP (−0.14 ± 0.1 vs. 0.01 ± 0.1; p < .001), CRI‐I (−0.69 ± 0.5 vs. 0.16 ± 0.5; p < .001) and CRI‐II (−0.50 ± 0.3 vs. 0.02 ± 0.3; p < .001). Garlic supplementation can improve intestinal transit time, LAP, and cardiometabolic indices.
Author Alizadeh, Mohammad
Parastouei, Karim
Hosseinzadeh, Mahdieh
Sangouni, Abbas Ali
Jamalzehi, Atena
Author_xml – sequence: 1
  givenname: Abbas Ali
  surname: Sangouni
  fullname: Sangouni, Abbas Ali
  organization: Shahid Sadoughi University of Medical Sciences
– sequence: 2
  givenname: Mohammad
  orcidid: 0000-0002-0593-1491
  surname: Alizadeh
  fullname: Alizadeh, Mohammad
  organization: Urmia University of Medical Sciences
– sequence: 3
  givenname: Atena
  surname: Jamalzehi
  fullname: Jamalzehi, Atena
  organization: Zahedan University of Medical Sciences
– sequence: 4
  givenname: Mahdieh
  orcidid: 0000-0001-7482-2494
  surname: Hosseinzadeh
  fullname: Hosseinzadeh, Mahdieh
  organization: Shahid Sadoughi University of Medical Sciences
– sequence: 5
  givenname: Karim
  orcidid: 0000-0002-8087-663X
  surname: Parastouei
  fullname: Parastouei, Karim
  email: parastouei@gmail.com
  organization: Baqiyatallah University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36721177$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9qFDEYxYNU7LYKPoEEvPHCWZNMdpJ4V4q2hYIiFbwL-beYJZOMScayPpZPaHa3tSCKV8nF75wv-c45AUcxRQfAc4yWGCHyZqp5yRjFj8ACIyE6vGL9EVggscIdxfzLMTgpZYMQEgTRJ-C4HxjBmLEF-HmhcvAGlnmaghtdrKr6FKEfp5y-uwJ9rK5UH1WANatYfIXVj-41DH7yFipj5nEOB1GT2NlUqKKFRmXr0-iq0mk3wEfrzd6vzdIbZ2qBt75-hQ9I2Uabm-QtPINtlE2j_-GaU4o1pxDatWavwlPweK1Ccc_uzlPw-f27m_PL7vrDxdX52XVnek5wp1ZGa86oQITrgbqBa8GIQooLZZ3QVFhGKRNc4AFR4nSv1wRbijTWGFPen4JXB9_2rW9zW4IcfTEuBBVdmoskvKdkRTCj_0cZw0Mvhr3ryz_QTZpzW-_OkJCecT7gRr24o2Y9Oiun7EeVt_I-uAYsD4DJqZTs1tL4Q3QtJR8kRnLXDNmaIXfNeHjib8G951_Q7oDe-uC2_-Tkx5tPe_4XeV7K2w
CitedBy_id crossref_primary_10_1186_s12933_023_02103_z
crossref_primary_10_3390_nu16030390
crossref_primary_10_1186_s12902_024_01661_x
crossref_primary_10_5937_scriptamed54_46932
Cites_doi 10.1186/1471-2288-4-26
10.1111/cen.12287
10.1186/1476-511X-6-5
10.1186/1471-2458-10-678
10.1016/j.trsl.2017.01.001
10.4162/nrp.2015.9.1.30
10.1016/j.clnesp.2021.06.015
10.3390/nu11122909
10.3390/nu11061225
10.1016/j.ctim.2020.102428
10.1038/s41522-022-00266-3
10.4103/2230-8210.91175
10.1016/j.dsx.2019.07.063
10.1016/j.arcmed.2019.08.009
10.3748/wjg.v20.i43.16079
10.5056/JNM19086
10.1002/em.20474
10.1007/s00018-017-2509-x
10.1093/jn/136.3.864 s
10.1016/j.pmedr.2017.07.004
10.1038/s41467-019-09964-7
10.1042/CS20030067
10.1016/j.dsx.2019.05.013
10.1016/j.cca.2014.08.042
10.18231/j.ijcbr.2020.055
10.3945/jn.109.105452
10.1186/s12889-017-4041-1
10.1016/j.phymed.2012.02.018
10.1017/S0007114520001403
10.1016/j.kjms.2016.10.003
10.1016/j.cca.2015.04.020
10.1016/j.dsx.2018.11.055
10.1079/bjn20041255
10.1186/s12986-017-0206-2
10.1080/19390211.2017.1358233
10.1007/s10067-018-4143-x
10.1002/ptr.2953
10.1016/j.dsx.2020.05.043
10.1002/ptr.7146
10.3390/nu10070812
10.3389/fnut.2018.00122
10.1111/j.1750-3841.2011.02114.x
10.1016/j.fct.2012.12.044
10.1016/j.clnesp.2021.11.023
10.5152/eurasianjmed.2019.18350
10.1016/j.nut.2014.02.014
10.1038/s41598-018-24130-7
10.1128/IAI.00647-12
10.4239/wjd.v6.i13.1246
10.1097/00005768-200009001-00009
10.1002/ptr.4796
10.1111/obr.12229
ContentType Journal Article
Copyright 2023 John Wiley & Sons Ltd.
2023 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2023 John Wiley & Sons Ltd.
– notice: 2023 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QP
7QR
7TK
7TM
8FD
FR3
K9.
P64
RC3
7X8
7S9
L.6
DOI 10.1002/ptr.7741
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
Genetics Abstracts
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Botany
EISSN 1099-1573
EndPage 2314
ExternalDocumentID 36721177
10_1002_ptr_7741
PTR7741
Genre article
Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: Baqiyatallah University of Medical Sciences, Tehran, Iran
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAYOK
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBD
EBS
ECGQY
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GWYGA
H.X
HF~
HGLYW
HHY
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WOHZO
WQJ
WRC
WUP
WVDHM
WWP
WXI
WXSBR
XG1
XV2
YCJ
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QP
7QR
7TK
7TM
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
P64
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c3821-a5cbb8749028b64e68b972a0a89ade9b49d744798916042eb3bf21d40b1b11483
IEDL.DBID DR2
ISSN 0951-418X
1099-1573
IngestDate Fri Jul 11 18:34:37 EDT 2025
Fri Jul 11 12:40:43 EDT 2025
Fri Jul 25 10:23:05 EDT 2025
Thu Apr 03 07:08:01 EDT 2025
Thu Apr 24 23:07:00 EDT 2025
Tue Jul 01 02:13:27 EDT 2025
Wed Jan 22 16:22:48 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords metabolic syndrome
garlic
lipid accumulation product
cardiometabolic
intestinal transit time
Language English
License 2023 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3821-a5cbb8749028b64e68b972a0a89ade9b49d744798916042eb3bf21d40b1b11483
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ORCID 0000-0001-7482-2494
0000-0002-8087-663X
0000-0002-0593-1491
PMID 36721177
PQID 2822378861
PQPubID 1036338
PageCount 10
ParticipantIDs proquest_miscellaneous_2834252174
proquest_miscellaneous_2771639648
proquest_journals_2822378861
pubmed_primary_36721177
crossref_citationtrail_10_1002_ptr_7741
crossref_primary_10_1002_ptr_7741
wiley_primary_10_1002_ptr_7741_PTR7741
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2023
2023-06-00
2023-Jun
20230601
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: June 2023
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Bognor Regis
PublicationSubtitle PTR
PublicationTitle Phytotherapy research
PublicationTitleAlternate Phytother Res
PublicationYear 2023
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
References 2010; 10
2017; 7
2019; 51
2013; 27
2019; 50
2019; 11
2019; 10
2019; 13
2016; 32
2004; 4
2020; 14
2012; 19
2012; 16
2006; 136
2014; 20
2021; 35
2020; 7
2018; 8
2017; 74
2018; 5
2010; 24
2013; 55
2009; 50
2020a; 124
2019; 25
2007; 6
2018; 37
2010; 8
2021; 47
2012; 80
2015; 6
2015; 16
2021; 44
2015; 446
2011; 76
2015; 9
2009; 139
2014; 81
2004; 92
2017; 14
2017; 17
2017; 16
2000; 32
2022; 8
2020b; 51
2017; 183
2015; 438
2003; 104
2014; 30
2005; 17
2018; 10
2018; 15
e_1_2_12_4_1
e_1_2_12_6_1
e_1_2_12_19_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_38_1
Sharifi F. (e_1_2_12_47_1) 2010; 8
e_1_2_12_20_1
e_1_2_12_41_1
e_1_2_12_22_1
e_1_2_12_43_1
e_1_2_12_24_1
e_1_2_12_45_1
e_1_2_12_26_1
Ashraf R. (e_1_2_12_3_1) 2005; 17
e_1_2_12_28_1
e_1_2_12_31_1
e_1_2_12_52_1
e_1_2_12_33_1
e_1_2_12_54_1
e_1_2_12_35_1
e_1_2_12_56_1
e_1_2_12_37_1
e_1_2_12_14_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_50_1
e_1_2_12_5_1
e_1_2_12_18_1
e_1_2_12_16_1
e_1_2_12_39_1
e_1_2_12_42_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_23_1
e_1_2_12_46_1
e_1_2_12_25_1
e_1_2_12_48_1
e_1_2_12_40_1
e_1_2_12_27_1
e_1_2_12_29_1
Sujatha R. (e_1_2_12_49_1) 2017; 16
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_32_1
e_1_2_12_55_1
e_1_2_12_34_1
e_1_2_12_36_1
e_1_2_12_15_1
e_1_2_12_13_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_9_1
References_xml – volume: 35
  start-page: 4433
  issue: 8
  year: 2021
  end-page: 4441
  article-title: Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial
  publication-title: Phytotherapy Research
– volume: 136
  start-page: 864S
  issue: 3Suppl
  year: 2006
  end-page: 869S
  article-title: Cancer chemoprevention by garlic and garlic‐containing sulfur and selenium compounds
  publication-title: The Journal of Nutrition
– volume: 16
  start-page: 7
  issue: 1
  year: 2012
  end-page: 12
  article-title: Changing definitions of metabolic syndrome
  publication-title: Indian Journal of Endocrinology and Metabolism
– volume: 8
  start-page: 68
  issue: 2
  year: 2010
  end-page: 73
  article-title: Effect of garlic on serum adiponectin and interleukin levels in women with metabolic syndrome
  publication-title: International Journal of Endocrinology and Metabolism
– volume: 37
  start-page: 2221
  issue: 8
  year: 2018
  end-page: 2231
  article-title: Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population
  publication-title: Clinical Rheumatology
– volume: 10
  start-page: 812
  issue: 7
  year: 2018
  article-title: Allicin bioavailability and bioequivalence from garlic supplements and garlic foods
  publication-title: Nutrients
– volume: 8
  start-page: 1
  issue: 1
  year: 2018
  end-page: 11
  article-title: Integrative metabolic and microbial profiling on patients with spleen‐yang‐deficiency syndrome
  publication-title: Scientific Reports
– volume: 4
  start-page: 26
  year: 2004
  article-title: Random allocation software for parallel group randomized trials
  publication-title: BMC Medical Research Methodology
– volume: 14
  start-page: 1217
  issue: 5
  year: 2020
  end-page: 1224
  article-title: Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre‐diabetes, and cardiovascular disease risk in Brazil
  publication-title: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
– volume: 16
  start-page: 1
  issue: 1
  year: 2015
  end-page: 12
  article-title: Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies
  publication-title: Obesity Reviews
– volume: 8
  start-page: 4
  issue: 1
  year: 2022
  article-title: Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine‐N‐oxide modulation
  publication-title: Npj Biofilms and Microbiomes
– volume: 51
  year: 2020b
  article-title: Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non‐alcoholic fatty liver disease: A randomized controlled clinical trial
  publication-title: Complementary Therapies in Medicine
– volume: 81
  start-page: 52
  issue: 1
  year: 2014
  end-page: 57
  article-title: Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study
  publication-title: Clinical Endocrinology
– volume: 446
  start-page: 231
  year: 2015
  end-page: 236
  article-title: Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease
  publication-title: Clinica Chimica Acta
– volume: 80
  start-page: 3786
  issue: 11
  year: 2012
  end-page: 3794
  article-title: Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae
  publication-title: Infection and Immunity
– volume: 9
  start-page: 30
  issue: 1
  year: 2015
  end-page: 36
  article-title: The effects of black garlic (allium satvium) extracts on lipid metabolism in rats fed a high fat diet
  publication-title: Nutrition Research and Practice
– volume: 20
  start-page: 16079
  issue: 43
  year: 2014
  end-page: 16094
  article-title: Gut microbiota and metabolic syndrome
  publication-title: World Journal of Gastroenterology
– volume: 7
  start-page: 254
  issue: 2
  year: 2020
  end-page: 259
  article-title: Castelli risk index‐1 and atherogenic coefficient are better predictors of cardiometabolic risk in patients with hypothyroidism
  publication-title: International Journal of Clinical Biochemistry and Research
– volume: 16
  start-page: 78
  issue: 2
  year: 2017
  end-page: 82
  article-title: Atherogenic indices in stroke patients: A retrospective study
  publication-title: Iranian Journal of Neurology
– volume: 139
  start-page: 2055
  issue: 11
  year: 2009
  end-page: 2060
  article-title: 1,2‐Vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes
  publication-title: The Journal of Nutrition
– volume: 10
  start-page: 1
  issue: 1
  year: 2019
  end-page: 11
  article-title: Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders
  publication-title: Nature Communications
– volume: 15
  start-page: 499
  issue: 4
  year: 2018
  end-page: 506
  article-title: Effect of raw crushed garlic (Allium sativum L.) on components of metabolic syndrome
  publication-title: Journal of Dietary Supplements
– volume: 14
  start-page: 1
  issue: 1
  year: 2017
  end-page: 9
  article-title: Lipid accumulation product is a powerful tool to predict non‐alcoholic fatty liver disease in Chinese adults
  publication-title: Nutrition and Metabolism
– volume: 50
  start-page: 285
  issue: 5
  year: 2019
  end-page: 294
  article-title: Atherogenic index of plasma: Novel predictive biomarker for cardiovascular illnesses
  publication-title: Archives of Medical Research
– volume: 17
  start-page: 60
  issue: 3
  year: 2005
  end-page: 64
  article-title: Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus
  publication-title: Journal of Ayub Medical College, Abbottabad
– volume: 6
  start-page: 5
  year: 2007
  article-title: Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
  publication-title: Lipids in Health and Disease
– volume: 44
  start-page: 130
  year: 2021
  end-page: 135
  article-title: Effect of omega‐3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non‐alcoholic fatty liver disease: A randomized controlled trial
  publication-title: Clinical Nutrition ESPEN
– volume: 27
  start-page: 637
  issue: 5
  year: 2013
  end-page: 646
  article-title: A review of the cardiovascular benefits and antioxidant properties of allicin
  publication-title: Phytotherapy Research
– volume: 13
  start-page: 2917
  issue: 5
  year: 2019
  end-page: 2922
  article-title: A review of synbiotic efficacy in non‐alcoholic fatty liver disease as a therapeutic approach
  publication-title: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
– volume: 24
  start-page: 374
  issue: 3
  year: 2010
  end-page: 378
  article-title: Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers
  publication-title: Phytotherapy Research
– volume: 11
  issue: 6
  year: 2019
  article-title: Preventive effects and mechanisms of garlic on dyslipidemia and gut microbiome dysbiosis
  publication-title: Nutrients
– volume: 13
  start-page: 792
  issue: 1
  year: 2019
  end-page: 799
  article-title: Prevalence of metabolic syndrome in Iran: A meta‐analysis of 69 studies
  publication-title: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
– volume: 124
  start-page: 450
  issue: 4
  year: 2020a
  end-page: 456
  article-title: Effect of garlic powder supplementation on hepatic steatosis, liver enzymes, and lipid profile in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trial
  publication-title: British Journal of Nutrition
– volume: 76
  start-page: T105
  issue: 4
  year: 2011
  end-page: T111
  article-title: Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells
  publication-title: Journal of Food Science
– volume: 47
  start-page: 51
  year: 2021
  end-page: 57
  article-title: Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled trial
  publication-title: Clinical Nutrition ESPEN
– volume: 25
  start-page: 625
  issue: 4
  year: 2019
  article-title: Stool consistency: Looking beyond the Bristol stool form scale
  publication-title: Journal of Neurogastroenterology and Motility
– volume: 11
  start-page: 2909
  issue: 12
  year: 2019
  article-title: Allicin improves metabolism in high‐fat diet‐induced obese mice by modulating the gut microbiota
  publication-title: Nutrients
– volume: 183
  start-page: 57
  year: 2017
  end-page: 70
  article-title: Cardiovascular consequences of metabolic syndrome
  publication-title: Translational Research
– volume: 5
  start-page: 122
  year: 2018
  article-title: The effect of Kyolic aged garlic extract on gut microbiota, inflammation, and cardiovascular markers in hypertensives: The GarGIC trial
  publication-title: Frontiers in Nutrition
– volume: 32
  start-page: 620
  issue: 12
  year: 2016
  end-page: 623
  article-title: Association between cardiometabolic index and erectile dysfunction: A new index for predicting cardiovascular disease
  publication-title: Kaohsiung Journal of Medical Sciences
– volume: 19
  start-page: 707
  issue: 8–9
  year: 2012
  end-page: 711
  article-title: Effect of garlic powder on the growth of commensal bacteria from the gastrointestinal tract
  publication-title: Phytomedicine
– volume: 50
  start-page: 247
  issue: 3
  year: 2009
  end-page: 265
  article-title: Biological properties of garlic and garlic‐derived organosulfur compounds
  publication-title: Environmental and Molecular Mutagenesis
– volume: 74
  start-page: 2959
  issue: 16
  year: 2017
  end-page: 2977
  article-title: Mechanisms and consequences of intestinal dysbiosis
  publication-title: Cellular and Molecular Life Sciences
– volume: 6
  start-page: 1246
  issue: 13
  year: 2015
  end-page: 1258
  article-title: Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
  publication-title: World Journal of Diabetes
– volume: 10
  start-page: 2
  year: 2010
  end-page: 7
  article-title: The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing metabolic syndrome among Malays in Kuala Lumpur
  publication-title: BMC Public Health
– volume: 55
  start-page: 100
  year: 2013
  end-page: 105
  article-title: Anti‐obesity effects of hot water extract and high hydrostatic pressure extract of garlic in rats fed a high‐fat diet
  publication-title: Food and Chemical Toxicology
– volume: 7
  start-page: 211
  year: 2017
  end-page: 215
  article-title: Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis
  publication-title: Preventive Medicine Reports
– volume: 438
  start-page: 274
  year: 2015
  end-page: 278
  article-title: The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus
  publication-title: Clinica Chimica Acta
– volume: 92
  start-page: 701
  issue: 4
  year: 2004
  end-page: 706
  article-title: Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo‐lipidaemic volunteers: A randomised, double‐blind, placebo‐controlled trial
  publication-title: British Journal of Nutrition
– volume: 51
  start-page: 171
  issue: 2
  year: 2019
  end-page: 175
  article-title: The clinical importance of the plasma atherogenic index, other lipid indexes, and urinary sodium and potassium excretion in patients with stroke
  publication-title: Eurasian Journal of Medicine
– volume: 32
  start-page: S498
  issue: 9 SUPPL
  year: 2000
  end-page: S504
  article-title: Compendium of physical activities: An update of activity codes and MET intensities
  publication-title: Medicine and Science in Sports and Exercise
– volume: 13
  start-page: 2260
  issue: 3
  year: 2019
  end-page: 2265
  article-title: A narrative review on effects of vitamin D on main risk factors and severity of non‐alcoholic fatty liver disease
  publication-title: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
– volume: 104
  start-page: 547
  issue: 6
  year: 2003
  end-page: 556
  article-title: Bioactive natural compounds for the treatment of gastrointestinal disorders
  publication-title: Clinical Science
– volume: 30
  start-page: 1034
  issue: 9
  year: 2014
  end-page: 1039
  article-title: Reduction of blood lipid parameters by a 12‐wk supplementation of aged black garlic: A randomized controlled trial
  publication-title: Nutrition
– volume: 17
  start-page: 1
  issue: 1
  year: 2017
  end-page: 9
  article-title: Prevalence and trends of metabolic syndrome among adults in the Asia‐pacific region: A systematic review
  publication-title: BMC Public Health
– ident: e_1_2_12_38_1
  doi: 10.1186/1471-2288-4-26
– ident: e_1_2_12_16_1
  doi: 10.1111/cen.12287
– ident: e_1_2_12_23_1
  doi: 10.1186/1476-511X-6-5
– ident: e_1_2_12_28_1
  doi: 10.1186/1471-2458-10-678
– ident: e_1_2_12_50_1
  doi: 10.1016/j.trsl.2017.01.001
– ident: e_1_2_12_15_1
  doi: 10.4162/nrp.2015.9.1.30
– ident: e_1_2_12_44_1
  doi: 10.1016/j.clnesp.2021.06.015
– ident: e_1_2_12_48_1
  doi: 10.3390/nu11122909
– ident: e_1_2_12_5_1
  doi: 10.3390/nu11061225
– ident: e_1_2_12_43_1
  doi: 10.1016/j.ctim.2020.102428
– ident: e_1_2_12_31_1
  doi: 10.1038/s41522-022-00266-3
– ident: e_1_2_12_32_1
  doi: 10.4103/2230-8210.91175
– ident: e_1_2_12_40_1
  doi: 10.1016/j.dsx.2019.07.063
– volume: 16
  start-page: 78
  issue: 2
  year: 2017
  ident: e_1_2_12_49_1
  article-title: Atherogenic indices in stroke patients: A retrospective study
  publication-title: Iranian Journal of Neurology
– ident: e_1_2_12_11_1
  doi: 10.1016/j.arcmed.2019.08.009
– ident: e_1_2_12_12_1
  doi: 10.3748/wjg.v20.i43.16079
– ident: e_1_2_12_52_1
  doi: 10.5056/JNM19086
– volume: 8
  start-page: 68
  issue: 2
  year: 2010
  ident: e_1_2_12_47_1
  article-title: Effect of garlic on serum adiponectin and interleukin levels in women with metabolic syndrome
  publication-title: International Journal of Endocrinology and Metabolism
– ident: e_1_2_12_17_1
  doi: 10.1002/em.20474
– volume: 17
  start-page: 60
  issue: 3
  year: 2005
  ident: e_1_2_12_3_1
  article-title: Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus
  publication-title: Journal of Ayub Medical College, Abbottabad
– ident: e_1_2_12_56_1
  doi: 10.1007/s00018-017-2509-x
– ident: e_1_2_12_10_1
  doi: 10.1093/jn/136.3.864 s
– ident: e_1_2_12_29_1
  doi: 10.1016/j.pmedr.2017.07.004
– ident: e_1_2_12_37_1
  doi: 10.1038/s41467-019-09964-7
– ident: e_1_2_12_14_1
  doi: 10.1042/CS20030067
– ident: e_1_2_12_41_1
  doi: 10.1016/j.dsx.2019.05.013
– ident: e_1_2_12_53_1
  doi: 10.1016/j.cca.2014.08.042
– ident: e_1_2_12_46_1
  doi: 10.18231/j.ijcbr.2020.055
– ident: e_1_2_12_21_1
  doi: 10.3945/jn.109.105452
– ident: e_1_2_12_34_1
  doi: 10.1186/s12889-017-4041-1
– ident: e_1_2_12_13_1
  doi: 10.1016/j.phymed.2012.02.018
– ident: e_1_2_12_42_1
  doi: 10.1017/S0007114520001403
– ident: e_1_2_12_9_1
  doi: 10.1016/j.kjms.2016.10.003
– ident: e_1_2_12_54_1
  doi: 10.1016/j.cca.2015.04.020
– ident: e_1_2_12_20_1
  doi: 10.1016/j.dsx.2018.11.055
– ident: e_1_2_12_51_1
  doi: 10.1079/bjn20041255
– ident: e_1_2_12_7_1
  doi: 10.1186/s12986-017-0206-2
– ident: e_1_2_12_6_1
  doi: 10.1080/19390211.2017.1358233
– ident: e_1_2_12_55_1
  doi: 10.1007/s10067-018-4143-x
– ident: e_1_2_12_24_1
  doi: 10.1002/ptr.2953
– ident: e_1_2_12_8_1
  doi: 10.1016/j.dsx.2020.05.043
– ident: e_1_2_12_39_1
  doi: 10.1002/ptr.7146
– ident: e_1_2_12_25_1
  doi: 10.3390/nu10070812
– ident: e_1_2_12_36_1
  doi: 10.3389/fnut.2018.00122
– ident: e_1_2_12_33_1
  doi: 10.1111/j.1750-3841.2011.02114.x
– ident: e_1_2_12_18_1
  doi: 10.1016/j.fct.2012.12.044
– ident: e_1_2_12_45_1
  doi: 10.1016/j.clnesp.2021.11.023
– ident: e_1_2_12_22_1
  doi: 10.5152/eurasianjmed.2019.18350
– ident: e_1_2_12_19_1
  doi: 10.1016/j.nut.2014.02.014
– ident: e_1_2_12_27_1
  doi: 10.1038/s41598-018-24130-7
– ident: e_1_2_12_35_1
  doi: 10.1128/IAI.00647-12
– ident: e_1_2_12_26_1
  doi: 10.4239/wjd.v6.i13.1246
– ident: e_1_2_12_2_1
  doi: 10.1097/00005768-200009001-00009
– ident: e_1_2_12_4_1
  doi: 10.1002/ptr.4796
– ident: e_1_2_12_30_1
  doi: 10.1111/obr.12229
SSID ssj0009204
Score 2.4199176
Snippet Subjects with metabolic syndrome (MetS) are at increased risk for cardiovascular disease (CVD). Altered gut microbiota is involved in the pathogenesis of MetS....
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2305
SubjectTerms Accumulation
cardiometabolic
Cardiovascular Diseases
Clinical trials
Diet
Dietary Supplements
Garlic
gastrointestinal transit
Health risks
Heart diseases
Humans
Intestinal microflora
intestinal microorganisms
Intestinal transit time
Intestine
Lipid Accumulation Product
Lipids
Metabolic disorders
Metabolic syndrome
Metabolic Syndrome - therapy
Pathogenesis
phytotherapy
Placebos
Powder
Powders
Random numbers
randomized clinical trials
Risk
Transit time
Title Garlic supplementation improves intestinal transit time, lipid accumulation product and cardiometabolic indices in subjects with metabolic syndrome: A randomized controlled trial
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fptr.7741
https://www.ncbi.nlm.nih.gov/pubmed/36721177
https://www.proquest.com/docview/2822378861
https://www.proquest.com/docview/2771639648
https://www.proquest.com/docview/2834252174
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBZlKaWXPtJX2m1RoaSXOBtbsiX1ti3dLoUtYclCoAejl8E0cULsHLI_q7-wGsmO2b4oPdngsSSj0eib0fgbhN4UirFUpSKybMoiagiNRFI4ZyUtithYw0kBjuLFl-z8in5epIs2qxL-hQn8EIeAG6wMb69hgUtVn_SkoZtmO3HYBTwfSNUCPHTZM0eJxFcO9FXkacwXHe_sNDnpXry5E_0CL2-iVb_dnN1HX7uBhiyTb5Ndoyb6-icOx__7kgfoXotC8WlQm4folq0G6Pb7tUOK-wG6c9EeuA_QaBaorfdjPO__1KrHeIRnPen1_hH6_klul6XGNVQJDRnpMOW49EELW2PgpXDmBLptYH8sGwx17cd4WW5Kg6XWu1VbSgxvAg0tlpXB2ifMrmzjtBU6gDN27dtzfSmIItUYgsm4F-lYGN7hU-y6MutVeW1dSyErf-lufa2Sx-jq7OP8w3nU1oOINOFJHMlUK8UZBcIZlVGbcSVYIqeSC2msUFQYRikT3EFeZ4usIqpIYkOnKlbg9pEn6KhaV_YZwqkWhFLt4ImyVCZESq4LySzVMQPYMERvO93IdUuWDjU7lnmgeU5yN2k5TNoQvT5IbgJByG9kjjv1ylsTUeeQvwtk_hk0cXjsFjec2MjKrndOhjl3loiM8r_IcOLsLniWQ_Q0qO5hICQDB5-xIRp5BfzjCPPZ_BKuz_9V8AW6mzi4F5LmjtFRs93Zlw6eNeqVX4g_AGAVPLU
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemgYAXPsrHCgOMhMpL0zWxEzvwNBCjwDpVUyf1ASmyHUeK1qZVkz50fxZ_IT47aTS-hHhKpFxsRz6ff3e-_A6h15lkLJRh7Gk2ZB5NCfXiIDPOSphlfqpTTjJwFMdn0eiCfpmFsz30rvkXxvFD7AJusDKsvYYFDgHpo5Y1dFWtBwa8GNfnBhT0tv7UecsdFQe2dqCtI099PmuYZ4fBUfPm9b3oF4B5Ha_aDefkHvrWDNXlmVwONpUcqKufWBz_81vuo7s1EMXHTnMeoD1ddNDN90sDFrcddGtcn7l3UG_i2K23fTxtf9Yq-7iHJy3v9fYh-v5JrOe5wiUUCnVJ6TDrOLdxC11ioKYwFgW6rWCLzCsMpe37eJ6v8hQLpTaLupoYXjkmWiyKFCubM7vQlVFY6ACO2ZVtz_QlIZBUYogn41akIWJ4i4-x6SpdLvIrbVpyiflzc2vLlTxCFycfpx9GXl0SwlOEB74nQiUlZxQ4Z2REdcRlzAIxFDwWqY4ljVNGKYu5Qb3GHGlJZBb4KR1KX4LnRx6j_WJZ6AOEQxUTSpVBKFJTERAhuMoE01T5DJBDF71plCNRNV86lO2YJ47pOUjMpCUwaV30aie5chwhv5E5bPQrqa1EmUAKL_D5R9DE7rFZ33BoIwq93BgZZjxaEkeU_0WGE2N6wbnsoidOd3cDIRH4-Ix1Uc9q4B9HmEym53B9-q-CL9Ht0XR8mpx-Pvv6DN0JDPpzOXSHaL9ab_Rzg9Yq-cKuyh_vG0DQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbQglZceJRXYQEjoXJpuknsxDa3haUsj11Vq65UaQ-R7ThSRJtWTXro_ix-IZ44abS8hDglUia2I4_H34wn3yD0OlOMRSoSnmE-82hKqCfCzDorUZYFqUk5ycBRPD2LTy7o51k0a7Iq4V8Yxw-xC7jByqjtNSzwVZoddqShq2o9stjFej43aexz0Ojj8446SoR16cC6jDwN-KwlnvXDw_bN61vRL_jyOlyt95vxXXTZjtSlmXwbbSo10lc_kTj-36fcQ3caGIqPnN7cRzdM0UO33i0tVNz20P5pc-LeQ4OJ47beDvG0-1WrHOIBnnSs19sH6PtHuZ7nGpdQJtSlpMOc47yOWpgSAzGFtSfQbQUbZF5hKGw_xPN8ladYar1ZNLXE8Mrx0GJZpFjXGbMLU1l1hQ7gkF3X7dm-FISRSgzRZNyJtDQMb_ERtl2ly0V-ZWxLLi1_bm_rYiUP0cX4w_T9idcUhPA04WHgyUgrxRkFxhkVUxNzJVgofcmFTI1QVKSMUia4xbzWGBlFVBYGKfVVoMDvI4_QXrEszBOEIy0IpdriE2WoDImUXGeSGaoDBrihj960upHohi0dinbME8fzHCZ20hKYtD56tZNcOYaQ38gctOqVNDaiTCCBF9j8Y2hi99iubjiykYVZbqwMs_4sETHlf5HhxBpecC376LFT3d1ASAwePmN9NKgV8I8jTCbTc7g-_VfBl2h_cjxOvn46-_IM3Q4t9HMJdAdor1pvzHML1Sr1ol6TPwAtKT-I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Garlic+supplementation+improves+intestinal+transit+time%2C+lipid+accumulation+product+and+cardiometabolic+indices+in+subjects+with+metabolic+syndrome%3A+A+randomized+controlled+trial&rft.jtitle=Phytotherapy+research&rft.au=Sangouni%2C+Abbas+Ali&rft.au=Alizadeh%2C+Mohammad&rft.au=Jamalzehi%2C+Atena&rft.au=Hosseinzadeh%2C+Mahdieh&rft.date=2023-06-01&rft.issn=1099-1573&rft.eissn=1099-1573&rft.volume=37&rft.issue=6&rft.spage=2305&rft_id=info:doi/10.1002%2Fptr.7741&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-418X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-418X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-418X&client=summon